SALT LAKE CITY, Sept. 9, 2025 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that Co-Dx™ was an honoree at the Utah Business…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Leading medical center is designing the future of healthcare with actionable data insights from the Qualtrics® XM Platform® PROVO, Utah and SEATTLE, Jan. 25, 2024 /PRNewswire/ — Qualtrics, the leader and creator of the experience […]
REC-3964 is designed to treat C. diff by selectively inhibiting the glucosyltransferase activity of toxin B produced by the bacterium in the gastrointestinal tract, offering a different mechanism of action from antibiotics. The post Recursion […]
Independent certification from global public health organization NSF demonstrates a commitment to personal care product quality and compliance with U.S. GMP requirements SALT LAKE CITY, Dec. 14, 2022 /PRNewswire/ — The Basic Research manufacturing facility […]
Copyright © 2026 Biotech Networks
